Thoratec Seeks Therapeutic VAD, Others Aim For Alternative-To-Transplant
This article was originally published in The Gray Sheet
Executive Summary
Thoratec plans to file a PMA supplement for a therapeutic recovery indication for the Thoratec ventricular assist device (VAD) by year-end.